Central Nervous System (CNS) Medication Use Before Suicide Among Older Adults in Sweden From 2007 to 2020: A Register‐Based Case‐Control Study
International Journal of Geriatric Psychiatry · 2026-06 · 41 (6)
DOI: 10.1002/gps.70235 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Geriatric Psychiatry, online erschienen am 20.06.2026. Verfasst von Theodore Tianyi Miao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Central Nervous System Agents, Suicide. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council for Health, Working Life and Welfare.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Older adults represent a high‐risk group for suicide and are frequently exposed to central nervous system (CNS) drugs. Yet, the role of CNS drugs in late‐life suicide remains unclear.
Methods
We conducted a nationwide register‐based matched case‐control study (1:30) including all individuals aged 65 years and older who died by suicide in Sweden between 2007 and 2020. Each case was matched to controls from the general population on age and sex, alive at the index date. Use of CNS medications was examined within 1‐month, 3‐month, and 12‐month windows prior to the index date (date of suicide). Conditional logistic regression was used to estimate odds ratios (ORs) with adjustment for sociodemographic factors, number of other classes of medications (proxy for comorbidities), frailty score, self‐harm history and major psychiatric diagnoses.
Results
Among 5971 older adults who died by suicide, 71.7% of cases used at least one type of CNS drug (vs. 35.2% of controls), while 34.7% of cases had dispensations for three or more CNS drug types (vs. 7.3% of controls) within one year before death by suicide. The most common drug classes among cases were hypnotics and sedatives (46.5%) and antidepressants (38.8%). About one third of cases used anxiolytics (32.3%) or minor analgesics and antipyretics (29.9%). Compared with controls, individuals who died by suicide more often used hypnotics and sedatives (adjusted OR 3.54, 95% CI 3.32–3.77), anxiolytics (aOR 3.27, 95% CI 3.04–3.52), antidepressants (aOR 2.50, 95% CI 2.33–2.68), and opioids (aOR 1.93, 95% CI 1.79–2.09) within 12 months before suicide. Patterns were consistent across time windows.
Conclusions
CNS medications are commonly dispensed before suicide in older adults, particularly hypnotics and sedatives, antidepressants, anxiolytics, and opioids. These findings describe medication use patterns preceding suicide and identify drug classes for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
ORCID-Profile: Theodore Tianyi Miao, Jonas W Wastesson
Förderung
- Swedish Research Council for Health, Working Life and Welfare
Zitieren
APA
Miao, T. T., Szilcz, M., Chang, Z., Wastesson, J. W., & Johnell, K. (2026). Central Nervous System (CNS) Medication Use Before Suicide Among Older Adults in Sweden From 2007 to 2020: A Register‐Based Case‐Control Study. International Journal of Geriatric Psychiatry, 41(6). https://doi.org/10.1002/gps.70235
Vancouver
Miao TT, Szilcz M, Chang Z, Wastesson JW, Johnell K. Central Nervous System (CNS) Medication Use Before Suicide Among Older Adults in Sweden From 2007 to 2020: A Register‐Based Case‐Control Study. International Journal of Geriatric Psychiatry. 2026;41(6). doi:10.1002/gps.70235
BibTeX
@article{Miao2026,
author = {Miao, Theodore Tianyi and Szilcz, Máté and Chang, Zheng and Wastesson, Jonas W and Johnell, Kristina},
title = {Central Nervous System (CNS) Medication Use Before Suicide Among Older Adults in Sweden From 2007 to 2020: A Register‐Based Case‐Control Study},
journal = {International Journal of Geriatric Psychiatry},
year = {2026},
volume = {41},
number = {6},
doi = {10.1002/gps.70235}
}
EUVIMED